Ocrelizumab
ATC L04AG08 · 10 markets · 21 records
AU 5 records · 5 strengths
- 920 mg/23 mLinjectionOCREVUS SC
- 300 mg/10 mLinjectionOCREVUS
- 300 mginjectionOCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial
- 920 mginjectionOCREVUS SC ocrelizumab 920 mg/23 mL solution for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 3 records · 2 strengths
- 920 mg/23 mLinjectionOcrevus 920mg/23ml solution for injection vials
- 300 mg/10 mLinjectionOcrevus 300mg/10ml concentrate for solution for infusion vials
US 2 records · 2 strengths
- 920 mg/23 mLinjectionOcrevus Zunovo
- 300 mg/10 mLinjectionOCREVUS
SG 2 records · 2 strengths
- 920 mg/23 mLinjectionOCREVUS SOLUTION FOR INJECTION 920MG/23ML
- 300 mg/10 mLinjectionOCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML
FR 2 records · 2 strengths
- 920 mg/23 mLinjectionOCREVUS 920 mg, solution injectable
- 300 mginjectionOCREVUS 300 mg, solution à diluer pour perfusion
CA 1 records · 1 strengths
- 30 mgliquidOCREVUS
ES 1 records · 1 strengths
- 300 mginjectionOCREVUS
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 920 mg/23 mL injection | Ocrevus Zunovo | Ocrevus 920mg/23ml solution for injection vials | OCREVUS SC | OCREVUS SOLUTION FOR INJECTION 920MG/23ML | OCREVUS 920 mg, solution injectable | |||||
| 300 mg/10 mL injection | OCREVUS | Ocrevus 300mg/10ml concentrate for solution for infusion vials | OCREVUS | OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML | ||||||
| 300 mg injection | OCREVUS ocrelizumab 300 mg/10 mL concentrate solution for infusion vial | OCREVUS | OCREVUS 300 mg, solution à diluer pour perfusion | |||||||
| 30 mg liquid | OCREVUS | |||||||||
| 920 mg injection | OCREVUS SC ocrelizumab 920 mg/23 mL solution for injection vial | |||||||||
unknown | OCREVUS | OCREVUS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/10ML | OCREVUS | |||||||
liquid | OCREVUS SC |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · MX and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · MX que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · MX 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 CA · MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.